Key result
Fetuses with prenatally diagnosed primary cardiomyopathy had an overall survival rate of 40%, with isolated right ventricular involvement being a significant predictor of survival (p=0.035).
Why the study?
The course and outcome of fetuses affected by primary cardiomyopathy required assessment.
Observational (n=21)
No
Prenatally diagnosed primary fetal cardiomyopathies are associated with a poor overall survival rate of 40%, though isolated right ventricular involvement and isolated noncompaction are associated with better outcomes.
Prenatal cardiomyopathy diagnosis warrants cautious counseling given high mortality; leaves open whether subtype-specific findings guide management.
Objective: to assess the course and outcome of fetuses affected by primary cardiomyopathy (CM). Methods: Retrospective study of 21 cases with prenatal diagnosis of a primary CM in one tertiary center over a period of 20 years. Charts were reviewed for echocardiographic findings, pregnancy outcome, and postnatal course. The utility of prenatal evaluation was discussed. Results: The mean gestational age (GA) at diagnosis was 26.7 (±5.1) weeks. A total of 33.3% (7/21) had associated anomalies. Genetic etiology was confirmed in 50.0% (10/20, with one case lost to follow up). The overall survival rate of the entire study population was 40% (8/20) including termination of pregnancy in 20% (4/20) and an intrauterine mortality rate of 5% (1/20). Of the initial survivors (n = 15), a neonatal and early infant mortality rate of 46.7% (7/15) was calculated. Prenatal isolated right ventricular involvement was the only identified significant parameter for survival (p = 0.035). Four phenotypical groups were identified: 42.9% (9/21) hypertrophic (HCM), 38.1% (8/21) dilated (DCM), 14.3% (3/21) isolated noncompaction (NCCM), and 4.8% (1/21) restrictive CM (RCM). Fetuses assigned to isolated NCCM revealed a 100% survival rate. Conclusion: Prenatal detection is feasible but needs to a introduce classification method for better consulting and management practices. A poor outcome is still observed in many cases, but an increase in examiners’ awareness may influence optimal multispecialized care.
No takes yet. Share an insight, caveat, or question.
Walter et al. (2023) conducted an observational in Fetal primary cardiomyopathy (n=21). Primary cardiomyopathy was evaluated on Overall survival. Fetuses with prenatally diagnosed primary cardiomyopathy had an overall survival rate of 40%, with isolated right ventricular involvement being a significant predictor of survival (p=0.035).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: